Integrated DNA Technologies (IDT) and Glycon Pty Ltd of New South Wales, Australia, are partnering to bring IDT's market leading products and services to researchers in Australia. IDT is among the world's most respected manufacturers of custom synthetic oligonucleotides and genes. Glycon will offer Australia's scientists local sales and technical support of IDT's products, complementing IDT's existing global customer care network available by phone, email and web chat. 

Glycon brings more than a decade's experience in Australia's biotechnology sector, with advanced expertise in both oligonucleotides and genetic research. Australian scientists will be able to work directly with Glycon to take the maximum advantage of IDT's entire product portfolio of synthetic DNA and RNA oligos, genes, and supporting products.

Wendy Scott, Executive Sales Manager of Gylcon explains the benefits of this relationship, "Our experience and knowledge of IDT's products enables us to provide exceptional customer service and technical expertise. With our background in biomedical science, broad product knowledge base and customer service experience, we can find the most effective solution for all research needs." 

For further information, please visit www.idtdna.com  

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com. 

About Glycon Pty Ltd

Founded in 2009, Glycon provides dedicated customer care and technical support to Australian researchers.  Glycon's 12 years' experience in custom nucleic acids and knowledge of the Australian biotechnology community combine to make Glycon the perfect partner for IDT in Australia.